These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10780826)

  • 1. Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.
    Schmitt U; Hiemke C
    Behav Pharmacol; 1999 Mar; 10(2):131-7. PubMed ID: 10780826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of GABA(A) receptor stimulation and GABA-transporter inhibition.
    Schmitt U; Lüddens H; Hiemke C
    Pharmacol Biochem Behav; 2000 Feb; 65(2):351-6. PubMed ID: 10672990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiagabine, a gamma-amino-butyric acid transporter inhibitor impairs spatial learning of rats in the Morris water-maze.
    Schmitt U; Hiemke C
    Behav Brain Res; 2002 Jul; 133(2):391-4. PubMed ID: 12110474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats.
    Schmitt U; Lüddens H; Hiemke C
    J Neural Transm (Vienna); 2002 May; 109(5-6):871-80. PubMed ID: 12111474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.
    Borden LA; Murali Dhar TG; Smith KE; Weinshank RL; Branchek TA; Gluchowski C
    Eur J Pharmacol; 1994 Oct; 269(2):219-24. PubMed ID: 7851497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic mechanisms of gabitril (tiagabine) and future potential developments.
    Meldrum BS; Chapman AG
    Epilepsia; 1999; 40 Suppl 9():S2-6. PubMed ID: 10612355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
    Sharma RP; Martis B; Davis JM; Omens R; Janicak PG
    J Clin Psychopharmacol; 2001 Jun; 21(3):347-9. PubMed ID: 11386503
    [No Abstract]   [Full Text] [Related]  

  • 8. Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1.
    Sitte HH; Singer EA; Scholze P
    Br J Pharmacol; 2002 Jan; 135(1):93-102. PubMed ID: 11786484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs.
    Eckstein-Ludwig U; Fei J; Schwarz W
    Br J Pharmacol; 1999 Sep; 128(1):92-102. PubMed ID: 10498839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependence of the anticonvulsant effects of the GABA uptake inhibitor tiagabine in vitro.
    Sabau A; Frahm C; Pfeiffer M; Breustedt J; Piechotta A; Numberger M; Engel D; Heinemann U; Draguhn A
    Eur J Pharmacol; 1999 Nov; 383(3):259-66. PubMed ID: 10594317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel GABA uptake inhibitors. 3. Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine as anticonvulsant agents.
    Knutsen LJ; Andersen KE; Lau J; Lundt BF; Henry RF; Morton HE; Naerum L; Petersen H; Stephensen H; Suzdak PD; Swedberg MD; Thomsen C; Sørensen PO
    J Med Chem; 1999 Sep; 42(18):3447-62. PubMed ID: 10479278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of background GABA uptake in rat hippocampal slices.
    Frahm C; Engel D; Draguhn A
    Neuroreport; 2001 Jun; 12(8):1593-6. PubMed ID: 11409722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GABA transporter and its inhibitors.
    Soudijn W; van Wijngaarden I
    Curr Med Chem; 2000 Oct; 7(10):1063-79. PubMed ID: 10911018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia.
    Costa C; Leone G; Saulle E; Pisani F; Bernardi G; Calabresi P
    Stroke; 2004 Feb; 35(2):596-600. PubMed ID: 14726544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
    McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
    Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1.
    Dalby NO; Thomsen C; Fink-Jensen A; Lundbeck J; Søkilde B; Man CM; Sørensen PO; Meldrum B
    Epilepsy Res; 1997 Jul; 28(1):51-61. PubMed ID: 9255599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
    Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
    Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.
    Suzdak PD; Swedberg MD; Andersen KE; Knutsen LJ; Braestrup C
    Life Sci; 1992; 51(24):1857-68. PubMed ID: 1333027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.